Novel P2X3 Inhibitors for Treating Neurogenic Disorders.

Provided herein are novel P2X3 inhibitors, pharmaceutical compositions, use of such compounds in treating neurogenic disorders, such as gynecological disorders, urinary tract disorders, respiratory disorders, and pain-associated disorders, and processes for preparing such compounds.